|Articles|January 10, 2017
Profil Institute Becomes ProSciento, Inc.
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc.
Advertisement
Profil Institute for Clinical Research, Inc. has announced the launch of its new corporate name, ProSciento Inc. Under a broader rebranding campaign, the name change represents the company’s focus on metabolism clinical R&D for diabetes, obesity and NAFLD/NASH.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
3
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
4
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
